Pharma Journalist -

CEPI, the Coalition for Epidemic Preparedness Innovations, and Dutch vaccine clinical development and manufacturing organization Intravacc, announced the latest funding award under…
Read More...

Intravacc announced that it has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases…
Read More...

BioLink Life Sciences of Cary, North Carolina, announced receiving a contract from BARDA (the Biomedical Advanced Research and Development Authority) to fund the development of…
Read More...

Pfizer Inc. announced the completion of its acquisition of Global Blood Therapeutics, Inc. (GBT), a biopharmaceutical company dedicated to the discovery, development and delivery of…
Read More...

Intravacc announced that it has been awarded a contract with base and options that may total US$14.6 million from the US National Institute of Allergy and Infectious Diseases (NIAID),…
Read More...

Myonex announced the completion of its acquisition of the clinical trial and packaging business of Hubertus Apotheke, located in Berlin, Germany. The new entity, Myonex GmbH, supports…
Read More...

Almac Clinical Services, a member of The Almac Group, the global contract development and manufacturing organisation, announces a new state-of-the-art Cryogenic Service Solution within…
Read More...

Personalis, Inc. has joined with Duke University and Olink Proteomics AB to form a research collaboration to study the effects of immunotherapy on advanced gastroesophageal cancer.…
Read More...

miRecule, Inc., an innovator of next-generation RNA therapeutics, announced a strategic collaboration and exclusive license agreement with Sanofi to develop and commercialize a…
Read More...

Japanese pharmaceutical company Shionogi & Co., Ltd. and the Medicines Patent Pool (MPP), a United Nations-backed public health organisation, reflecting a shared commitment to…
Read More...